InGeNA Limited

Health economics studies play a key role for decision making as we mainstream the adoption of genomics into our health systems. This week, we want to share two recent publications: ⭐ Health Care Costs After Genome-Wide Sequencing for Children With Rare Diseases in England and Canada Read more: https://lnkd.in/edCG-Y8P ⭐ Cost-Effectiveness of Plasma Microbial Cell-Free DNA Sequencing When Added to Usual Care Diagnostic Testing for Immunocompromised Host Pneumonia Read more | https://lnkd.in/ewCheyaN A special thanks to James Buchanan for sharing these. #genomics #healtheconomics #DNAsequencing #diagnostics #innovation #rarediseases

Collaboration and relationships make all the difference. Last week in Melbourne, it was wonderful to meet with Tiffany Boughtwood and Monica Ferrie, and we even had time for a fun group photo 📸 🤩 Our longstanding collaboration with Australian Genomics allows us to address key issues directly and take a coordinated approach between research and industry. This visit was also significant as it was the first time our CEO met our Consumer Advisory Group (CAG) Chair, Monica Ferrie in person. Monica is a powerhouse and a super connector in genomics and consumer lived experience. We discussed the next steps for our CAG and solidified our shared commitment to a collaborative approach with consumers. We are fortunate to have these trusted relationships, which are crucial for making a difference and accelerating the adoption of healthcare innovations to benefit patients' lives. Looking forward to the impact we will create together. #genomics #precisionmedicine #consumerlivedexperience #innovation #healthcareinnovation

Accelerating access to human genomics needs to go hand in hand with equity. At InGeNA we the back the importance of equitable access of genomics for all Australians. The World Health Organization held their first regional Expert Meeting on Accelerating Access to Human Genomics for Public Health took place in Manila, Philippines in April. They brought together experts from national genomic initiatives and included Tiffany Boughtwood from Australian Genomics. The meeting highlighted the need to raise awareness of the benefits and risks of human genomics. There is a growing number of engaging public materials being produced. Additionally the work in the West Pacific highlight the overwhelming recognition of the stark lack of diversity in large-scale international human genomic initiatives, with far smaller inclusion of those coming from less-resourced countries and underrepresented groups. This limits the ability to derive equitable benefits from genomic medicine and presents potential negative consequences The meeting insights underscore the multifaceted nature of the opportunities and challenges in accelerating access to human genomics for public health in the Western Pacific Region.They highlight the need for coordinated action at the national, regional, and global levels to realize the transformative potential of human genomics.  Read highlights of the meeting below 👇 https://shorturl.at/YVJGB #healthequity #genomics #humangenomics #publichealth #diversity Photo credit WHO / Mark Vincent Limchoa

We are looking forward to attending the Queensland Health Genomics Seminar Series - Session 1 on Thursday, July 25 · 4 - 5pm AEST The inaugural session will spotlight three of the most recent Queensland Health distinguished Genomics Clinical Research Fellows. They will present the background and plans for their fellowship project. Keynote Speaker 1 Prof Elizabeth Powell Investigating the maladaptive tissue repair response in chronic liver disease and the impact of sexual dimorphism.  Keynote Speaker 2 A/Prof Bryan Chan  The LAMp-LC study: illuminating the lung- airway microbiome and its impact on lung cancer development, progression and treatment response. Keynote Speaker 3 A/Prof Krispin Hajkowicz  Rapid clinical genomics to transform diagnosis of febrile neutropenia in people with a haematological malignancy. Register here https://lnkd.in/gbZuBVBU

🚀 Week one for our new CEO wrapped up! It’s been fantastic meeting our members and key ecosystem builders in Melbourne. It might have been a cold snap but a warm welcome from InGeNA board, members, and stakeholders for the warm welcome. Highlights from the first week: 🤝 Engaging with Members: Insightful discussions about their priorities. Great to meet with Oliver Bonaccorso from Johnson & Johnson. At the Transcendomics meeting we discussed their innovative genomic information management infrastructure with Dr Natalie Thorne, CHIA, GAICD and Michelle Kleynhans. Thanks Nick Devereaux, Kirby Siemering PhD GAICD and their intern Nick Wenzel from 23Strands for the deep discussion about the current issues. ⭐ Great catch up with Sarah Powell from our CAG – we shared a lot even the love of pink and importantly the role of our CAG.  📣 Dr Eric Green, M.D. Seminar: A fantastic presentation of the history and bold future for genomics. The 4th Chapter of Genonomics has a clear focus on the role of industry working collaborating with research and the health system. 🗒 Australian Genomics Boardroom lunch with Eric Green and ecosystem leaders. Great to connect and listen to the shared issues as we shift to mainstreaming genomics into healthcare and to present the Industry voice at the table. We look forward to ongoing engagement. Thanks to Australian Genomics and Professor Kathryn North for the invite. Ecosystem Collaboration: Great discussions with Camille Shanahan at Jumar Bioincubator. Wonderful for our CEO to meet @Ausbiotech CEO Rebekah Cassidy GAICD & Catalyst Director Dr Marguerite Evans-Galea AM Looking forward to continuing these vital conversations and driving better access to genomic medicine for all Australians. 🌟 Fantastic meeting with Dr Rachel C. from Brooker Consulting who are great enablers of leadership in the sector. 🧠 Wonderful to discuss the plans for the Industry 4.0 conference we are supporting that is being organised by Ian Lucas at SeerPharma. Industry 4.0 is key to our sector and we are delighted to be collaborating. If we missed you this week, I'll be visiting Melbourne 17-19 July and am always interested to catch up! 🌟 #genomics #precisionmedicine #advancedtherapies #collaboration #ecosystem

Happy NAIDOC Week (7-14 July 2024) InGeNA celebrates and recognizes the history, culture, and achievements of Aboriginal and Torres Strait Islander peoples. We acknowledge that NAIDOC Week is an opportunity for all Australians to learn about First Nations cultures and histories. It is a time to participate in celebrations that honor the world's oldest, continuous living cultures. By taking part in various events and activities nationwide, you can show your support and build connections with local Indigenous communities. This year’s theme, chosen by the National NAIDOC Committee, is Keep the Fire Burning! Blak, Loud & Proud. The theme honors the enduring strength and vitality of First Nations culture, with fire symbolizing a deep connection to Country, each other, and the rich tapestry of traditions that define Aboriginal and Torres Strait Islander peoples. To learn more about NAIDOC and activities to get involved, visit: NAIDOC 2024 Theme. This vibrant theme encourages us all to work together to Keep The Fire Burning 🔥🔥🔥. #NAIDOC #NAIDOC2024 #NAIDOCWeek

Welcome to our new CEO, Dr Erin Evans

🌟 New Financial Year - Day 1 for our new CEO, Dr Erin Evans. Erin has hit the ground and is in Melbourne for events and meetings with our valued members and partners. 🙏 We extend our gratitude to Australian Genomics for inviting us to a boardroom lunch and seminar with the distinguished guest Dr. Eric Green, MD. 🤝 Erin is eager to meet with members and partners this week and beyond, aiming to strengthen our collaborations and partnerships. 💡 We are excited to work together with the board, our members and the broader ecosystem to shape a better future for all Australians through improved access to precision medicine. Kathy Campbell Sue McKean Carl Stubbings Mark G. Rob McBride Diana Nielson #NewCEO #Leadership #Genomics #PrecisionMedicine #Collaboration #HealthcareInnovation #InGeNA #Melbourne #AustralianGenomics

We hope to see you at our webinar on Tuesday 25 June from 11am to 12pm EDT / 4pm to 5pm BST with Professor David Veenstra on whether we should conduct genomic screening for all adults! International Health Economics Association #IHEA #healtheconomics #genomics #precisionmedicine James Buchanan Deirdre Weymann Hadley Smith Samantha Pollard Zanfina Ademi Zhuo Chen Michael Abbott Tianjiao Wang Cun(Lizzy) Liu Dr. Dimple Butani

Join us next Tuesday, June 25th, 2024 at 11:00 AM EDT/3:00 PM UTC for the upcoming webinar "Econ-Omics Talks: Should we conduct genomic screening for all adults? Clinical and economic outcomes using simulation modeling." During this webinar Professor David Veenstra will present his research evaluating the benefits, risks, and costs of population-level genomic screening for adults. Drivers, barriers, and evidence gaps for both rare, high-risk genomic variants and more common moderate risk stratification approaches will be discussed. This presentation is part of the Econ-Omics Talks series and will include a brief speaker interview in addition to a research seminar. Register now: https://lnkd.in/gkvP5PGF Featured Speaker: Professor David Veenstra David Veenstra is a Professor in the CHOICE Institute at the University of Washington in Seattle. His research focus is evaluating the clinical, economic, and policy implications of precision medicine. His major research projects include evaluation of the cost effectiveness of population-level genomic screening. Professor Veenstra teaches courses in health economics and managed care and is an author of five book chapters and 250 peer-reviewed publications.